LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Q3 2017 13F Holders as of 9/30/2017

Type / Class
Debt / NOTE 0.750% 8/1
Number of holders
25
Total Principal
241M
Shares change
-1.22M
Total reported value, excl. options
$441M
Value change
-$93.5K
Put/Call ratio
0
Number of buys
10
Number of sells
-11
Price
$1.82
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.